CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE, the worldwide leader in diagnosing, profiling, tracking and elucidating rare diseases for patients, clinicians and pharmaceutical partners,…

Richard Stoffelen is our Chief Financial Officer and was recently acknowledged for his outstanding work by the FINANCE MONTHLY magazine.

This year…

The Ship of Tolerance, a global art project, initiated 2005 and driven over the past years by the artists Ilya & Emilia Kabakov, will be shown for the…

Aiding the analysis of hereditary disorders by integrating genomic and clinical databases

An agreement was recently signed for an exciting new collaboration between CENTOGENE, Germany and University Hospital St. Ivan Rilski Sofia, Bulgaria.…

CENTOGENE is proud to announce today our Euro 25 million financing round led by TVM Capital Life Science in cooperation with DPE Deutsche Private…

CENTOGENE GmbH (CENTOGENE) has been working together for years with local, national, and international partners in developing biomarkers to be used in…

The ‘Rare Disease Day’ is celebrated every February, to help raise awareness and build community for all those affected by rare genetic diseases.

Our new headquarter in Rostock, CentoNew, is growing rapidly – we started the countdown to our move-in November 2017.

The new headquarter in Rostock…

CENTOGENE GmbH (CENTOGENE) and Genetic Associates announce their strategic collaboration for the Australian/New Zealand market for offering high-end…

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads